Report for Ismaili L

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (30)

Title : The Proof-of-Concept of MBA121, a Tacrine-Ferulic Acid Hybrid, for Alzheimer's Disease Therapy - Rodriguez-Ruiz_2023_Int.J.Mol.Sci_24_
Author(s) : Rodriguez-Ruiz ER , Herrero-Labrador R , Fernandez-Fernandez AP , Serrano-Masa J , Martinez-Montero JA , Gonzalez-Nieto D , Hana-Vaish M , Benchekroun M , Ismaili L , Marco-Contelles J , Martinez-Murillo R
Ref : Int J Mol Sci , 24 : , 2023
Abstract : Rodriguez-Ruiz_2023_Int.J.Mol.Sci_24_
ESTHER : Rodriguez-Ruiz_2023_Int.J.Mol.Sci_24_
PubMedSearch : Rodriguez-Ruiz_2023_Int.J.Mol.Sci_24_
PubMedID: 37569630

Title : Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment - Dakhlaoui_2023_Int.J.Mol.Sci_24_
Author(s) : Dakhlaoui I , Bernard PJ , Pietrzak D , Simakov A , Maj M , Refouvelet B , Beduneau A , Cornu R , Jozwiak K , Chabchoub F , Iriepa I , Martin H , Marco-Contelles J , Ismaili L
Ref : Int J Mol Sci , 24 : , 2023
Abstract : Dakhlaoui_2023_Int.J.Mol.Sci_24_
ESTHER : Dakhlaoui_2023_Int.J.Mol.Sci_24_
PubMedSearch : Dakhlaoui_2023_Int.J.Mol.Sci_24_
PubMedID: 37298693

Title : Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation - Malek_2022_Molecules_28_
Author(s) : Malek R , Simakov A , Davis A , Maj M , Bernard PJ , Wnorowski A , Martin H , Marco-Contelles J , Chabchoub F , Dallemagne P , Rochais C , Jozwiak K , Ismaili L
Ref : Molecules , 28 : , 2022
Abstract : Malek_2022_Molecules_28_
ESTHER : Malek_2022_Molecules_28_
PubMedSearch : Malek_2022_Molecules_28_
PubMedID: 36615267

Title : Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments - Bautista-Aguilera_2021_Chem.Rec_21_162
Author(s) : Bautista-Aguilera O M , Ismaili L , Iriepa I , Diez-Iriepa D , Chabchoub F , Marco-Contelles J , Perez M
Ref : Chem Rec , 21 :162 , 2021
Abstract : Bautista-Aguilera_2021_Chem.Rec_21_162
ESTHER : Bautista-Aguilera_2021_Chem.Rec_21_162
PubMedSearch : Bautista-Aguilera_2021_Chem.Rec_21_162
PubMedID: 33169934

Title : Synthesis of new Hantzsch adducts showing Ca(2+) channel blockade capacity, cholinesterase inhibition and antioxidant power - Pachon-Angona_2021_Future.Med.Chem__
Author(s) : Pachon-Angona I , Maj M , Wnorowski A , Martin H , Jozwiak K , Ismaili L
Ref : Future Med Chem , : , 2021
Abstract : Pachon-Angona_2021_Future.Med.Chem__
ESTHER : Pachon-Angona_2021_Future.Med.Chem__
PubMedSearch : Pachon-Angona_2021_Future.Med.Chem__
PubMedID: 34402661

Title : (+\/-)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3beta Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease - Ismaili_2021_ACS.Chem.Neurosci__
Author(s) : Ismaili L , Monnin J , Etievant A , Arribas RL , Viejo L , Refouvelet B , Soukup O , Janockova J , Hepnarova V , Korabecny J , Kucera T , Jun D , Andrys R , Musilek K , Baguet A , Garcia-Frutos EM , De Simone A , Andrisano V , Bartolini M , de los Rios C , Marco-Contelles J , Haffen E
Ref : ACS Chem Neurosci , : , 2021
Abstract : Ismaili_2021_ACS.Chem.Neurosci__
ESTHER : Ismaili_2021_ACS.Chem.Neurosci__
PubMedSearch : Ismaili_2021_ACS.Chem.Neurosci__
PubMedID: 33797877

Title : Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease Therapy - Bautista-Aguilera_2020_Int.J.Mol.Sci_21_
Author(s) : Bautista-Aguilera OM , Ismaili L , Chioua M , Andrys R , Schmidt M , Bzonek P , Martinez-Grau MA , Beadle CD , Vetman T , Lopez-Munoz F , Iriepa I , Refouvelet B , Musilek K , Marco-Contelles J
Ref : Int J Mol Sci , 21 : , 2020
Abstract : Bautista-Aguilera_2020_Int.J.Mol.Sci_21_
ESTHER : Bautista-Aguilera_2020_Int.J.Mol.Sci_21_
PubMedSearch : Bautista-Aguilera_2020_Int.J.Mol.Sci_21_
PubMedID: 32486316

Title : Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy - do Carmo Carreiras_2020_Bioorg.Med.Chem.Lett_30_126880
Author(s) : do Carmo Carreiras M , Ismaili L , Marco-Contelles J
Ref : Bioorganic & Medicinal Chemistry Lett , 30 :126880 , 2020
Abstract : do Carmo Carreiras_2020_Bioorg.Med.Chem.Lett_30_126880
ESTHER : do Carmo Carreiras_2020_Bioorg.Med.Chem.Lett_30_126880
PubMedSearch : do Carmo Carreiras_2020_Bioorg.Med.Chem.Lett_30_126880
PubMedID: 31864798

Title : Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives - Pachon_2020_Int.J.Mol.Sci_21_
Author(s) : Pachon Angona I , Martin H , Daniel S , Moraleda I , Bonet A , Wnorowski A , Maj M , Jozwiak K , Iriepa I , Refouvelet B , Marco-Contelles J , Ismaili L
Ref : Int J Mol Sci , 21 : , 2020
Abstract : Pachon_2020_Int.J.Mol.Sci_21_
ESTHER : Pachon_2020_Int.J.Mol.Sci_21_
PubMedSearch : Pachon_2020_Int.J.Mol.Sci_21_
PubMedID: 33081112

Title : Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease Therapy - Zribi_2020_Molecules_25_
Author(s) : Zribi L , Pachon-Angona I , Bautista-Aguilera OM , Diez-Iriepa D , Marco-Contelles J , Ismaili L , Iriepa I , Chabchoub F
Ref : Molecules , 25 : , 2020
Abstract : Zribi_2020_Molecules_25_
ESTHER : Zribi_2020_Molecules_25_
PubMedSearch : Zribi_2020_Molecules_25_
PubMedID: 32668671

Title : New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition - Malek_2019_J.Med.Chem_62_11416
Author(s) : Malek R , Arribas RL , Palomino-Antolin A , Totoson P , Demougeot C , Kobrlova T , Soukup O , Iriepa I , Moraleda I , Diez-Iriepa D , Godyn J , Panek D , Malawska B , Gluch-Lutwin M , Mordyl B , Siwek A , Chabchoub F , Marco-Contelles J , Kiec-Kononowicz K , Egea J , de los Rios C , Ismaili L
Ref : Journal of Medicinal Chemistry , 62 :11416 , 2019
Abstract : Malek_2019_J.Med.Chem_62_11416
ESTHER : Malek_2019_J.Med.Chem_62_11416
PubMedSearch : Malek_2019_J.Med.Chem_62_11416
PubMedID: 31724859

Title : Synthesis and Biological Evaluation of Novel Chromone+Donepezil Hybrids for Alzheimer's Disease Therapy - Malek_2019_Curr.Alzheimer.Res_16_815
Author(s) : Malek R , Refouvelet B , Benchekroun M , Iriepa I , Moraleda I , Andrys R , Musilek K , Marco-Contelles J , Ismaili L
Ref : Curr Alzheimer Res , 16 :815 , 2019
Abstract : Malek_2019_Curr.Alzheimer.Res_16_815
ESTHER : Malek_2019_Curr.Alzheimer.Res_16_815
PubMedSearch : Malek_2019_Curr.Alzheimer.Res_16_815
PubMedID: 31660831

Title : Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy - Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
Author(s) : Pachon-Angona I , Refouvelet B , Andrys R , Martin H , Luzet V , Iriepa I , Moraleda I , Diez-Iriepa D , Oset-Gasque MJ , Marco-Contelles J , Musilek K , Ismaili L
Ref : J Enzyme Inhib Med Chem , 34 :479 , 2019
Abstract : Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
ESTHER : Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
PubMedSearch : Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
PubMedID: 30712420

Title : Chromenones as Multineurotargeting Inhibitors of Human Enzymes - Lemke_2019_ACS.Omega_4_22161
Author(s) : Lemke C , Christmann J , Yin J , Alonso JM , Serrano E , Chioua M , Ismaili L , Martinez-Grau MA , Beadle CD , Vetman T , Dato FM , Bartz U , Elsinghorst PW , Pietsch M , Muller CE , Iriepa I , Wille T , Marco-Contelles J , Gutschow M
Ref : ACS Omega , 4 :22161 , 2019
Abstract : Lemke_2019_ACS.Omega_4_22161
ESTHER : Lemke_2019_ACS.Omega_4_22161
PubMedSearch : Lemke_2019_ACS.Omega_4_22161
PubMedID: 31891098

Title : Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy - Dgachi_2019_J.Enzyme.Inhib.Med.Chem_34_163
Author(s) : Dgachi Y , Martin H , Malek R , Jun D , Janockova J , Sepsova V , Soukup O , Iriepa I , Moraleda I , Maalej E , Carreiras MC , Refouvelet B , Chabchoub F , Marco-Contelles J , Ismaili L
Ref : J Enzyme Inhib Med Chem , 34 :163 , 2019
Abstract : Dgachi_2019_J.Enzyme.Inhib.Med.Chem_34_163
ESTHER : Dgachi_2019_J.Enzyme.Inhib.Med.Chem_34_163
PubMedSearch : Dgachi_2019_J.Enzyme.Inhib.Med.Chem_34_163
PubMedID: 30482062

Title : Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease - Chioua_2018_Eur.J.Med.Chem_155_839
Author(s) : Chioua M , Buzzi E , Moraleda I , Iriepa I , Maj M , Wnorowski A , Giovannini C , Tramarin A , Portali F , Ismaili L , Lopez-Alvarado P , Bolognesi ML , Jozwiak K , Menendez JC , Marco-Contelles J , Bartolini M
Ref : Eur Journal of Medicinal Chemistry , 155 :839 , 2018
Abstract : Chioua_2018_Eur.J.Med.Chem_155_839
ESTHER : Chioua_2018_Eur.J.Med.Chem_155_839
PubMedSearch : Chioua_2018_Eur.J.Med.Chem_155_839
PubMedID: 29958119

Title : Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy - Dgachi_2017_Future.Med.Chem_9_715
Author(s) : Dgachi Y , Martin H , Bonet A , Chioua M , Iriepa I , Moraleda I , Chabchoub F , Marco-Contelles J , Ismaili L
Ref : Future Med Chem , 9 :715 , 2017
Abstract : Dgachi_2017_Future.Med.Chem_9_715
ESTHER : Dgachi_2017_Future.Med.Chem_9_715
PubMedSearch : Dgachi_2017_Future.Med.Chem_9_715
PubMedID: 28504912

Title : Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases - Bautista-Aguilera_2017_Angew.Chem.Int.Ed.Engl_56_12765
Author(s) : Bautista-Aguilera OM , Hagenow S , Palomino-Antolin A , Farre-Alins V , Ismaili L , Joffrin PL , Jimeno ML , Soukup O , Janockova J , Kalinowsky L , Proschak E , Iriepa I , Moraleda I , Schwed JS , Romero Martinez A , Lopez-Munoz F , Chioua M , Egea J , Ramsay RR , Marco-Contelles J , Stark H
Ref : Angew Chem Int Ed Engl , 56 :12765 , 2017
Abstract : Bautista-Aguilera_2017_Angew.Chem.Int.Ed.Engl_56_12765
ESTHER : Bautista-Aguilera_2017_Angew.Chem.Int.Ed.Engl_56_12765
PubMedSearch : Bautista-Aguilera_2017_Angew.Chem.Int.Ed.Engl_56_12765
PubMedID: 28861918

Title : Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease - Ismaili_2017_Prog.Neurobiol_151_4
Author(s) : Ismaili L , Refouvelet B , Benchekroun M , Brogi S , Brindisi M , Gemma S , Campiani G , Filipic S , Agbaba D , Esteban G , Unzeta M , Nikolic K , Butini S , Marco-Contelles J
Ref : Prog Neurobiol , 151 :4 , 2017
Abstract : Ismaili_2017_Prog.Neurobiol_151_4
ESTHER : Ismaili_2017_Prog.Neurobiol_151_4
PubMedSearch : Ismaili_2017_Prog.Neurobiol_151_4
PubMedID: 26797191

Title : New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease - Boulebd_2017_Future.Med.Chem_9_723
Author(s) : Boulebd H , Ismaili L , Martin H , Bonet A , Chioua M , Marco Contelles J , Belfaitah A
Ref : Future Med Chem , 9 :723 , 2017
Abstract : Boulebd_2017_Future.Med.Chem_9_723
ESTHER : Boulebd_2017_Future.Med.Chem_9_723
PubMedSearch : Boulebd_2017_Future.Med.Chem_9_723
PubMedID: 28485637

Title : Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy - Dgachi_2016_Eur.J.Med.Chem_126_576
Author(s) : Dgachi Y , Sokolov O , Luzet V , Godyn J , Panek D , Bonet A , Martin H , Iriepa I , Moraleda I , Garcia-Iriepa C , Janockova J , Richert L , Soukup O , Malawska B , Chabchoub F , Marco-Contelles J , Ismaili L
Ref : Eur Journal of Medicinal Chemistry , 126 :576 , 2016
Abstract : Dgachi_2016_Eur.J.Med.Chem_126_576
ESTHER : Dgachi_2016_Eur.J.Med.Chem_126_576
PubMedSearch : Dgachi_2016_Eur.J.Med.Chem_126_576
PubMedID: 27918993

Title : ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy - Marco-Contelles_2016_Front.Neurosci_10_294
Author(s) : Marco-Contelles J , Unzeta M , Bolea I , Esteban G , Ramsay RR , Romero A , Martinez-Murillo R , Carreiras MC , Ismaili L
Ref : Front Neurosci , 10 :294 , 2016
Abstract : Marco-Contelles_2016_Front.Neurosci_10_294
ESTHER : Marco-Contelles_2016_Front.Neurosci_10_294
PubMedSearch : Marco-Contelles_2016_Front.Neurosci_10_294
PubMedID: 27445665

Title : Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Abeta1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy - Dgachi_2016_ChemMedChem_11_1318
Author(s) : Dgachi Y , Ismaili L , Knez D , Benchekroun M , Martin H , Szalaj N , Wehle S , Bautista-Aguilera OM , Luzet V , Bonnet A , Malawska B , Gobec S , Chioua M , Decker M , Chabchoub F , Marco-Contelles J
Ref : ChemMedChem , 11 :1318 , 2016
Abstract : Dgachi_2016_ChemMedChem_11_1318
ESTHER : Dgachi_2016_ChemMedChem_11_1318
PubMedSearch : Dgachi_2016_ChemMedChem_11_1318
PubMedID: 26804623

Title : Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease Therapy - Boulebd_2016_Molecules_21_
Author(s) : Boulebd H , Ismaili L , Bartolini M , Bouraiou A , Andrisano V , Martin H , Bonet A , Moraleda I , Iriepa I , Chioua M , Belfaitah A , Marco-Contelles J
Ref : Molecules , 21 : , 2016
Abstract : Boulebd_2016_Molecules_21_
ESTHER : Boulebd_2016_Molecules_21_
PubMedSearch : Boulebd_2016_Molecules_21_
PubMedID: 27023499

Title : The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators - Benchekroun_2016_J.Med.Chem_59_9967
Author(s) : Benchekroun M , Romero A , Egea J , Leon R , Michalska P , Buendia I , Jimeno ML , Jun D , Janockova J , Sepsova V , Soukup O , Bautista-Aguilera OM , Refouvelet B , Ouari O , Marco-Contelles J , Ismaili L
Ref : Journal of Medicinal Chemistry , 59 :9967 , 2016
Abstract : Benchekroun_2016_J.Med.Chem_59_9967
ESTHER : Benchekroun_2016_J.Med.Chem_59_9967
PubMedSearch : Benchekroun_2016_J.Med.Chem_59_9967
PubMedID: 27736061

Title : Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer's Disease - Dgachi_2016_Molecules_21_
Author(s) : Dgachi Y , Bautista-Aguilera OM , Benchekroun M , Martin H , Bonet A , Knez D , Godyn J , Malawska B , Gobec S , Chioua M , Janockova J , Soukup O , Chabchoub F , Marco-Contelles J , Ismaili L
Ref : Molecules , 21 : , 2016
Abstract : Dgachi_2016_Molecules_21_
ESTHER : Dgachi_2016_Molecules_21_
PubMedSearch : Dgachi_2016_Molecules_21_
PubMedID: 27187348

Title : Donepezil-ferulic acid hybrids as anti-Alzheimer drugs - Benchekroun_2015_Future.Med.Chem_7_15
Author(s) : Benchekroun M , Ismaili L , Pudlo M , Luzet V , Gharbi T , Refouvelet B , Marco-Contelles J
Ref : Future Med Chem , 7 :15 , 2015
Abstract : Benchekroun_2015_Future.Med.Chem_7_15
ESTHER : Benchekroun_2015_Future.Med.Chem_7_15
PubMedSearch : Benchekroun_2015_Future.Med.Chem_7_15
PubMedID: 25582330

Title : Novel tacrine-grafted ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic Acid hybrids - Benchekroun_2015_ChemMedChem_10_523
Author(s) : Benchekroun M , Bartolini M , Egea J , Romero A , Soriano E , Pudlo M , Luzet V , Andrisano V , Jimeno ML , Lopez MG , Wehle S , Gharbi T , Refouvelet B , de Andres L , Herrera-Arozamena C , Monti B , Bolognesi ML , Rodriguez-Franco MI , Decker M , Marco-Contelles J , Ismaili L
Ref : ChemMedChem , 10 :523 , 2015
Abstract : Benchekroun_2015_ChemMedChem_10_523
ESTHER : Benchekroun_2015_ChemMedChem_10_523
PubMedSearch : Benchekroun_2015_ChemMedChem_10_523
PubMedID: 25537267

Title : Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease - Pudlo_2014_Bioorg.Med.Chem_22_2496
Author(s) : Pudlo M , Luzet V , Ismaili L , Tomassoli I , Iutzeler A , Refouvelet B
Ref : Bioorganic & Medicinal Chemistry , 22 :2496 , 2014
Abstract : Pudlo_2014_Bioorg.Med.Chem_22_2496
ESTHER : Pudlo_2014_Bioorg.Med.Chem_22_2496
PubMedSearch : Pudlo_2014_Bioorg.Med.Chem_22_2496
PubMedID: 24657052

Title : Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists - Tomassoli_2011_Eur.J.Med.Chem_46_1
Author(s) : Tomassoli I , Ismaili L , Pudlo M , de los Rios C , Soriano E , Colmena I , Gandia L , Rivas L , Samadi A , Marco-Contelles J , Refouvelet B
Ref : Eur Journal of Medicinal Chemistry , 46 :1 , 2011
Abstract : Tomassoli_2011_Eur.J.Med.Chem_46_1
ESTHER : Tomassoli_2011_Eur.J.Med.Chem_46_1
PubMedSearch : Tomassoli_2011_Eur.J.Med.Chem_46_1
PubMedID: 21111515